Company intelligence
CeQur
Our mission is to simplify the lives of people with diabetes
About CeQur
CeQur®, a medical device company dedicated to simplifying mealtime insulin delivery for individuals on multiple daily injections, manufactures CeQur Simplicity, a simple-to-use wearable insulin delivery device enabling discreet, convenient and injection-free bolus dosing. In June 2024, the company announced the FDA's recent 510(k) clearance of CeQur Simplicity for an extended wear duration from 3 to 4 days. One CeQur Simplicity 4-day wearable patch holds up to 200 units of rapid-acting insulin administered in two-unit increments and replaces, on average, twelve daily mealtime injections over four days. CeQur is headquartered in Horw, Switzerland. Please visit myceqursimplicity.com for more information.
Verified activity
Signals from CeQur
3 published signals
Presence & Recognition
CeQur Simplicity was represented by Lindsey at the Indiana University School of Medicine Midwest Diabetes Update and Tech Course to connect with healthcare professionals and share conversations about new tools, treatment advances, and diabetes care.
Reported by CeQur
Products & Services
CeQur Simplicity is expanding to offer 2U and 1U dosing options and up to 7-day wear
Reported by CeQur
Presence & Recognition
CeQur Simplicity was discussed in an educational program featuring Natalie Bellini, DNP, BC-ADM, and CDCES.
Reported by CeQur